Antidepressant Decision Aid for Major Depressive Disorder Patients
NCT ID: NCT04761757
Last Updated: 2021-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
752 participants
INTERVENTIONAL
2019-12-01
2020-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
NCT00759395
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479
AZD6765 Severe Major Depressive Disorder (MDD) IV
NCT00781742
Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients
NCT02012504
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
NCT01436162
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm
Booklet of Scripts of Doctors
The "Booklet of Scripts for Doctors" was used in the control arm. This tool was developed and tested to encourage shared decision-making in prescribing antidepressants within the Malaysian context.
Intervention Arm
Booklet of Scripts for Doctors and the Antidepressant Decision Aid for Major depressive disorder patients (ADAM)
The "Booklet of Scripts for Doctors" along with the "Antidepressant Decision Aid for Major depressive disorder patients, ADAM", was used in the intervention arm. The decision aid was developed as per the International Patient Decision Aid Standards (IPDAS) criteria to enhance patient understanding of risks and benefits of different antidepressants available within the Malaysian context.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Booklet of Scripts of Doctors
The "Booklet of Scripts for Doctors" was used in the control arm. This tool was developed and tested to encourage shared decision-making in prescribing antidepressants within the Malaysian context.
Booklet of Scripts for Doctors and the Antidepressant Decision Aid for Major depressive disorder patients (ADAM)
The "Booklet of Scripts for Doctors" along with the "Antidepressant Decision Aid for Major depressive disorder patients, ADAM", was used in the intervention arm. The decision aid was developed as per the International Patient Decision Aid Standards (IPDAS) criteria to enhance patient understanding of risks and benefits of different antidepressants available within the Malaysian context.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No psychotic symptoms
* Based on psychiatrist's clinical judgement currently in need for antidepressant treatment.
* Functional English literacy and language skills (to use the decision aid and fill out the questionnaires)
* Provides consent
Exclusion Criteria
* Communication barriers (visual impairment, language barrier)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Education, Malaysia
OTHER_GOV
University of Malaya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aya Ahmed Abousheishaa
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Ng Chong Guan
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia Asia Hospital
Iskandar Puteri, Johor, Malaysia
Hospital Permai
Johor Bahru, Johor, Malaysia
Sultanah Aminah Hospital
Johor Bahru, Johor, Malaysia
KPJ Ampang Puteri Specialist Hospital
Ampang, Kuala Lumpur, Malaysia
Dr Seed Specialist Clinic
Kepong, Kuala Lumpur, Malaysia
Hospital Pengajar Universiti Putra Malaysia
Serdang, Kuala Lumpur, Malaysia
Hospital Sultan Haji Ahmad Shah
Temerluh, Pahang, Malaysia
Hospital Raja Permaisuri Bainun
Ipoh, Perak, Malaysia
Hospital Pulau Pinang
George Town, Pulau Pinang, Malaysia
Hospital Umum Sarawak
Kuching, Sarawak, Malaysia
A. H. Lee Specialist Clinic
Petaling Jaya, Selangor, Malaysia
Hospital Sultanah Nur Zahirah
Kuala Terengganu, Terengganu, Malaysia
Hospital Pusrawi
Kuala Lumpur, , Malaysia
Klinik Pakar Dr Yeoh & Dr Hazli Mental Health Specialist
Kuala Lumpur, , Malaysia
Pusat Perubatan Universiti Kebangsaan Malaysia
Kuala Lumpur, , Malaysia
University of Malaya Medical Centre
Kuala Lumpur, , Malaysia
Hospital Putrajaya
Putrajaya, , Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADAM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.